BiotechTube
Health Technology Innovations

Health Technology Innovations

New York, United States· Est.
hti.ai
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Health Technology Innovations (HTI) is a private, early-revenue company leveraging artificial intelligence to revolutionize the cryo-EM workflow for drug discovery. Its core business combines a fee-for-service cryo-EM structural analysis offering with a software-as-a-service (SaaS) platform designed to automate the most time-consuming steps in single-particle analysis. The company has secured non-dilutive grant funding from entities like the National Science Foundation and the Oregon Innovation Council, validating its technological approach, and has formed strategic partnerships with protein production CROs to offer integrated services. HTI operates at the intersection of AI, structural biology, and pharmaceutical R&D, targeting the significant inefficiencies in current drug discovery pipelines.

AI / Machine Learning

Technology Platform

CryoDiscovery™ and CryoFAST™: AI/ML software platforms that automate cryo-EM image processing, particle picking, 2D/3D classification, and data collection to accelerate single-particle analysis workflows for drug discovery.

Opportunities

The rapid adoption of cryo-EM in pharmaceutical R&D, coupled with a severe shortage of expert practitioners, creates a massive demand for automation software and outsourced services.
HTI's integrated software-and-service model allows it to capture value across the entire workflow.
Strategic partnerships, like the one with KanPro, enable vertical integration and a more compelling one-stop-shop offering for clients.

Risk Factors

HTI faces competition from established cryo-EM software vendors also integrating AI, and its complex technology must consistently deliver superior, reliable performance in diverse real-world conditions to gain adoption.
The company's reliance on a limited number of large pharma clients and non-dilutive grant funding introduces concentration and financial sustainability risks.

Competitive Landscape

HTI competes with established cryo-EM software suites like cryoSPARC and RELION, which are integrating their own AI features, and with large instrument manufacturers like Thermo Fisher Scientific that offer bundled hardware-software solutions. Its differentiation lies in a dedicated focus on end-to-end AI automation for the entire workflow (data collection via CryoFAST™ to processing via CryoDiscovery™) and a hybrid model that validates software through its own service division.

More companies in AI / Machine Learning →More companies in United States →